Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 08/26/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–08/25/2026 Record Record Date Vuga Group Change Status Recency Days Public Significance Score Michigan Contraceptive Access, Research, and Evaluation Study: Phase 1 09/17/2018 INTERVENTIONAL unchanged 2,900.85 0 Ribociclib and Letrozole Treatment in Ovarian Cancer 09/17/2018 INTERVENTIONAL unchanged 2,900.85 0 Fetoscopic Endoluminal Tracheal Occlusion 09/17/2018 INTERVENTIONAL unchanged 2,900.85 0 Evaluation of an Online, Remote Cognitive Battery for Use in Cancer Survivorship 09/17/2018 OBSERVATIONAL unchanged 2,900.85 0 RESOLVE: Abemaciclib + Letrozole +/- Metformin or Gedatolisib in Endometrial Cancer 09/18/2018 INTERVENTIONAL unchanged 2,899.85 0 Dietary Management of Gestational Diabetes 09/21/2018 INTERVENTIONAL unchanged 2,896.85 0 Preoperative Virtual Reality to Reduce Pain on Gynaecologic Patients Undergoing Surgery 09/26/2018 INTERVENTIONAL unchanged 2,891.85 0 An Ultrasound Guided Automated Spinal Landmark Identification System 09/27/2018 INTERVENTIONAL unchanged 2,890.85 0 Feasibility Study of Uterine Transplantation From Living Donors in Terms of Efficacy and Safety in Patients With Mayer-Rokitansky-Küster-Hauser Syndrome (MRKH) 09/28/2018 INTERVENTIONAL unchanged 2,889.85 0 Comparation of Treatment Strategies for OVF: Teriparatide Injection and PVP 10/02/2018 OBSERVATIONAL unchanged 2,885.85 0 mHealth Integrated Model of Hypertension, Diabetes and Antenatal Care in India and Nepal 10/09/2018 INTERVENTIONAL unchanged 2,878.85 0 Study of Hysteroscopic Repeat Curettage as the First-line Treatment in Low-risk Postmolar Gestational Trophoblastic Neoplasia 10/11/2018 INTERVENTIONAL unchanged 2,876.85 0 Tocotrienols for Obesity of Postmenopausal Women 10/15/2018 INTERVENTIONAL unchanged 2,872.85 0 A Study of Flibanserin in Breast Cancer Survivors on Tamoxifen or Aromatase Inhibitors 10/16/2018 INTERVENTIONAL unchanged 2,871.85 0 PAGETEX® Photodynamic Therapy Device for the Treatment of Extra Mammary Paget's Disease of the Vulva (EMPV). 10/19/2018 INTERVENTIONAL unchanged 2,868.85 0 Robot-assisted Approach to Cervical Cancer 10/25/2018 INTERVENTIONAL unchanged 2,862.85 0 Exploring Respiratory Health Outcomes From Sustained Use of Efficient Cookstoves 11/01/2018 INTERVENTIONAL unchanged 2,855.85 0 A Multi-Modality Surveillance Program for Women at High Risk for Breast Cancer 11/02/2018 INTERVENTIONAL unchanged 2,854.85 0 Delayed-immediate Versus Delayed Breast Reconstruction in Breast Cancer Patients With Mastectomy and Radiation Therapy 11/05/2018 INTERVENTIONAL unchanged 2,851.85 0 Online Psychosocial Intervention in Improving Social Well-Being and Support in Women With Stage I-IV Non-small Cell Lung Cancer Undergoing Treatment 11/06/2018 INTERVENTIONAL unchanged 2,850.85 0 Evaluation of Individual Sensitivity to the Gonadotoxicity of Chemotherapy in Young Patients With Breast Cancer 11/06/2018 INTERVENTIONAL unchanged 2,850.85 0 Pembrolizumab in Treating Participants With Recurrent Ovarian Cancer 11/07/2018 INTERVENTIONAL unchanged 2,849.85 0 Peer Approaches to Lupus Self-management 11/07/2018 INTERVENTIONAL unchanged 2,849.85 0 Systemic Immune Checkpoint Blockade and Intraperitoneal Chemo-Immunotherapy in Recurrent Ovarian Cancer 11/08/2018 INTERVENTIONAL unchanged 2,848.85 0 Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients 11/09/2018 INTERVENTIONAL unchanged 2,847.85 0 An mHealth Intervention to Improve Outcomes for Women With HIV/AIDS 11/13/2018 INTERVENTIONAL unchanged 2,843.85 0 The Role of Estrogen in the Neurobiology of Eating Disorders 11/14/2018 INTERVENTIONAL unchanged 2,842.85 0 A Study of Novel Anti-cancer Agents in Patients With Metastatic Triple Negative Breast Cancer 11/15/2018 INTERVENTIONAL unchanged 2,841.85 0 Cardiovascular Disease Risk in Women With Endometriosis 11/19/2018 INTERVENTIONAL unchanged 2,837.85 0 Exercise to Prevent AnthraCycline-based Cardio-Toxicity Study 2.0 (EXACT2) 11/21/2018 INTERVENTIONAL unchanged 2,835.85 0 3D Animation and Models to Aid Management of Fetal CDH 11/23/2018 OBSERVATIONAL unchanged 2,833.85 0 Validation Study on RENEW's Aingeal at KK Women's and Children's Hospital 11/23/2018 INTERVENTIONAL unchanged 2,833.85 0 Cancer Driving Mutations in Endometriosis Lesions and Development of Progesterone Resistance 11/28/2018 OBSERVATIONAL unchanged 2,828.85 0 Collection of Donated Placenta for Isolation of Mitochondria for Research and for Future Use in Mitochondrial Augmentation Therapies 12/03/2018 OBSERVATIONAL unchanged 2,823.85 0 AMBULAPSE STUDY Feasibility Study on Laparoscopic Double-mesh Sacrocolpopexy With or Without Robotic Assistance, in Female Patients Presenting With Symptomatic Pelvic Organ Prolapse, Based on an Outpatient Treatment Model. 12/05/2018 INTERVENTIONAL unchanged 2,821.85 0 Increasing Patients' Engagement in Breast Cancer Surgery Decision-Making 12/05/2018 INTERVENTIONAL unchanged 2,821.85 0 LAparoscopic Preventive PRErectal Mesh 12/05/2018 INTERVENTIONAL unchanged 2,821.85 0 Short Term Aspirin on the Biologic and Immunologic Changes of the Fallopian Tube 12/11/2018 INTERVENTIONAL unchanged 2,815.85 0 Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC) 12/11/2018 INTERVENTIONAL unchanged 2,815.85 0 Post Operative Cognitive Dysfunction After Breast Surgery 12/13/2018 OBSERVATIONAL unchanged 2,813.85 0 Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise 12/14/2018 OBSERVATIONAL unchanged 2,812.85 0 Exploring the Potential of Novel Biomarkers Based on Plasma microRNAs for a Better Management of Pelvic Gynecologic Tumors 12/17/2018 INTERVENTIONAL unchanged 2,809.85 0 Metabolic and Bone Changes After Adjuvant Cancer Treatments in Early Non-metastatic Breast Cancer 12/24/2018 OBSERVATIONAL unchanged 2,802.85 0 Vaginal Cuff Brachytherapy Fractionation Study 12/24/2018 INTERVENTIONAL unchanged 2,802.85 0 Study of Different Therapeutic Strategies in Hydatidiform Mole With Lung Nodule 12/24/2018 INTERVENTIONAL unchanged 2,802.85 0 Intensity Modulated Radiation Therapy or 3-Dimensional Conformal Radiation Therapy in Treating Patients With Lymph-Node Positive Breast Cancer 12/26/2018 INTERVENTIONAL unchanged 2,800.85 0 One Week Versus Three Week in Adjuvant Radiotherapy in Breast Cancer 12/27/2018 INTERVENTIONAL unchanged 2,799.85 0 Patch vs. No Patch Fetoscopic Meningomyelocele Repair Study 01/04/2019 INTERVENTIONAL unchanged 2,791.85 0 Quantify the Degree of Pain Relief of Pelvic Congestion Syndrome Following Gonadal Vein Embolization 01/07/2019 OBSERVATIONAL unchanged 2,788.85 0 Follow-up of Sequential Chemotherapy and Stimulation for Fertility Preservation in Young Patients With Breast Cancer 01/07/2019 INTERVENTIONAL unchanged 2,788.85 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 08/26/2026 · upstream last modified 08/26/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Public Significance Score using the documented compute method. · methodology